PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients
Jing Huang, Jingmei Xiao, Zhuang Peng, Ping Shao, Mengxi Sun, Yujun Long, Xiaoyi Wang, Manjun Shen, Dongyu Kang, Ye Yang, Xingjie Peng, Weiyan Wang, Peng Xie, Tiannan Shao, Jingping Zhao, Renrong Wu
Topics & Concepts
OlanzapineDyslipidemiaPCSK9EndocrinologyInternal medicineSchizophrenia (object-oriented programming)Atypical antipsychoticMedicinePharmacologyCholesterolLipoproteinAntipsychoticLDL receptorPsychiatryDiabetes mellitusLipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismSchizophrenia research and treatment